ALICE CARROLL: Open Payments
NPI 1235769381 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 57 payments from 9 companies in 2025. Trend: 2023 $317 · 2024 $737 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $205 |
| ABBVIE INC. | 12 | $202 |
| Ardelyx, Inc. | 8 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| PFIZER INC. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Braintree Laboratories, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: REZDIFFRA, RINVOQ, IBSRELA, ENTYVIO, XIFAXAN, EOHILIA, VOQUEZNA, VELSIPITY.
Industry payments across IN — which companies pay providers there.
